reviewTop 1% cited
Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy · 2013 · Vol. 69(4) · pp. 881–891
Claudia Slimings✉(University of Western Australia)Thomas V. Riley(Pathwest Laboratory Medicine)
Abstract
The risk of HA-CDI remains greatest for cephalosporins and clindamycin, and their importance as inciting agents should not be minimized. The importance of fluoroquinolones should not be overemphasized, particularly if fluoroquinolone-resistant epidemic strains of C. difficile are absent.
Clostridium difficile and Clostridium perfringens researchMicroscopic ColitisNosocomial Infections in ICUClostridium difficileAntibioticsClostridium InfectionsMedicineMicrobiologyMeta-analysisC difficileIntensive care medicineBiologyInternal medicine
MeSH terms
Anti-Bacterial AgentsClostridium InfectionsCross InfectionDiarrheaHospitalsHumansClostridioides difficile
Citations
585
FWCI
18.57
field-weighted impact
References
39
Percentile
100%
vs. same field & year
Citations per year
References
Measuring inconsistency in meta-analyses
BMJ · 2003 · 61,700 citations
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Journal of Clinical Epidemiology · 2009 · 19,782 citations
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
PLoS Medicine · 2007 · 21,248 citations
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
Medical Entomology and Zoology · 2014 · 17,868 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.